CD274 and cancer: Nowadays, checkpoint blockade, in particular the targeting of programmed cell death-1 (PD-1)/(PD-1) ligand (PD-L1) pathway, is considered one of the most promising anti-cancer treatments and enormous therapeutic benefits have been reported for its use in different cancer types [3].